The Brain Tumour Charity is governed by our Board of Trustees, who meet formally four times a year. In addition, they meet as members of various sub-committees and provide advice to the management team throughout the year. Our Trustees have a wealth of experience in the fields of finance, business and medicine.
The tenure of Peter McDermott and Maryanne Roach as Trustees has come to an end. We are very grateful to have had their time, passion and contribution to our work. Read how Peter and Maryanne have made a difference.
We are indebted to our Trustees for giving their time freely and providing so much support and help. Sadly a number of our Trustees have in common the loss of a loved one to a brain tumour. This terrible experience only serves to spur them on to do as much as possible in supporting the The Charity to find a cure for brain tumours.
| || |
Sir Martin Narey (Chair)
Sir Martin Narey took up the role of Chair of Trustees on 1 April 2015.
Sir Martin began his working life in the NHS before training as a prison governor. He went on to become director general of the prison service in England and Wales and was the first chief executive of the National Offender Management Service.
He left the civil service in 2005 to become chief executive of Barnardo’s, a position he held for six years. Since 2011 he has advised government on adoption and other children’s issues.
Sir Martin said: “I am delighted to take on this role. I have been lucky enough to be able to consider a number of approaches to become a charity chair in the last year or so. But of all the charities with which I have had conversations, The Brain Tumour Charity stood out for several reasons. I am impressed that their overheads are genuinely tiny and that they spend nearly every penny they raise on medical research and raising awareness of this terrible disease."
“They have made a measurable impact and their ambitions are exciting. I hope I can help them achieve their goals.”
| || |
Neil Dickson MBE (Vice-Chair)
Neil, with wife Angela, established the Samantha Dickson Research Trust in 1996 following the loss of their daughter Samantha to a brain tumour. The organisation then became the Samantha Dickson Brain Tumour Trust and, most recently, The Brain Tumour Charity.
The Brain Tumour Charity is now the second largest charity in the world focussing solely on brain tumours. Neil previously set up his own aviation business which employed 100 staff with a turnover approaching £20 million. Neil attends many events and conferences to promote The Charity and our work and is a key media spokesperson for The Charity.
| || |
Graham Lindsay (Vice-Chair)
Graham Lindsay joined the board of Brain Tumour UK in August 2010 and comes to The Charity holding the position of Managing Director, Customer Experience, for the Lloyds Banking Group. He has worked for the group for 34 years and he has vast experience in all aspects of banking, most recently in implementing projects to improve customer service and ensure that customers are looked after during times of large mergers. Recent appointments for Graham have been as Managing Director for the Wales & West branch network, and interim Human Resources Director for the retail bank. Until recently Graham was as a Board member for another charity, the Institute of Financial Services, which he served for six years. He has been married to Judy for 25 years and they have two sons, Ben and Oliver.
| || |
Tim joined the board in December 2012 following the merger with Brain Tumour UK. Tim sat on the board of trustees at The Joseph Foote Trust for just over a year before the Trust merged with Brain Tumour UK in April 2012 where his involvement at board level continued. He has established, grown and sold the largest independent estate agency in the Midlands. Tim now holds a number of consultancy positions at high profile property related businesses. Having seen his friend's experience of the loss of his child as a result of a brain tumour, he felt compelled to offer his extensive knowledge to help the fight against the condition. Tim lives with his wife and three daughters in Solihull. He is a keen sports fan, wine connoisseur and gardener.
| || |
Angela became a trustee of Brain Tumour UK in May 2004 and following the merger in December 2012 now serves as the Company Secretary for The Charity. She had her own practice in Stratford for 25 years, specialising in conveyancing, wills probate and divorce. She is a member of the Law Society Council, which is the ruling body of all solicitors and also sits on the complaints committee of the Law Society. Angela gained significant trustee experience in 2004 when she was appointed Chairman of the Board of Trustees of the Shakespeare Hospice. Her role involved chairing meetings, fundraising and liaising with other hospices and the NHS. Angela lost her husband, Bob, to a malignant glioma in 1998.
| || |
Angela Dickson MBE Angela founded The Charity with husband Neil and since then has worked tirelessly to raise funds and awareness of brain tumours. Angela attends many events to promote The Charity and liaises with our Patrons. Angela worked as a PA for a director of a large London company before having her three children.
| || |
Andy founded and ran The Joseph Foote Trust for over 10 years before its merger with Brain Tumour UK and subsequently The Brain Tumour Charity in 2012. Following the diagnosis of his son’s brain tumour in 2000, Andy has raised over £2,000,000 to fund research at Nottingham University’s Children’s Brain Tumour Research Centre. The loss of Andy’s son Joseph in 2007 strengthened his resolve to fight the disease.
After a professional football career was cut short by injury, Andy pursued a career in the motor trade, before becoming self employed in 1994. Andy has held a number of business interests including motor finance, recruitment and property in Birmingham and the West Midlands.
Andy has a substantial knowledge of brain tumours and their treatments, having travelled throughout Europe and North America during his son’s treatment.
He and his wife Judy live with their daughter Nancie and three dogs in Solihull.
| || |
Nigel joined the board in April 2012 following the merger of The Joseph Foote Trust with Brain Tumour UK and has actively been involved in a number of charities for over 25 years. In this time Nigel has completed 2 London Marathons and subsequently went on to organise 5 marathon teams, as well as hosting a number of large events together with his wife Helen at their home in Lapworth, all raising considerable amounts for charity. Nigel brings a wealth of knowledge in legal Wills & Probate practice and in legacy administration, areas which are key to the development of the charity in the coming years.
| || |
Simon Hay is the CEO of dunnhumby – an analytics and technology company that uses data and science to delight customers and grow the sales of their retailer and brand clients (such as Tesco, Macy's, P&G and Coca-Cola). Simon was the first full time employee working alongside the two founders and has seen the company grow to 2,200 employees working in 70+ countries. The business is one of the few UK technology companies valued at $1 billion+. dunnhumby's Helping Hands program allows employees in every country to support their chosen charities with fundraising support and providing our services and experience. This led to engagement with The Brain Tumour Charity and Simon was so impressed with the team, the cause and the approach to changing the outcome for patients that he became a trustee in 2015 and is delighted to be part of the team.
| || |
Philippa also joined The Brain Tumour Charity in 2008. Philippa has a background in central government, having held a number of senior posts in HM Treasury and HM Revenue and Customs. Philippa is also a member of Great Ormond Street Hospital’s Transformation Board and Director of Dasic Marine Limited, a marine engineering business based in Hampshire. Philippa has taken a career break since her 15 month old son, Lawrence, was diagnosed with a brain tumour. She cared for him until he passed away in September 2007 aged 3 years 9 months. Philippa is Chair of our Information and Support Sub-Committee and serves as a member of the Research Sub-Committee having a degree in Biochemistry.
| || |
Berendina Norton (Berrie)
Berrie is the Pianoforte Professor at the Royal Military School of Music. She began her career as a civil servant which included working as Assistant Private Secretary to Michael Heseltine, the then Defence Secretary. Berrie is married to Graham and they have two children. Their eldest child, Michael, died of an aggressive brain tumour in 2000. Berrie is a member of the Information and Support Sub-Committee.
| || |
Graham is a qualified chartered accountant and Group Financial Controller for a FTSE 250 company. As well as being a longstanding Trustee, Graham has 25 years' experience in finance at companies such as Cable and Wireless and Reuters.
| || |
Having served on the board of Brain Tumour UK since 2008, Robert joined the board of The Charity in December 2012. After 20 years’ experience in sales, marketing and business management in the UK, Europe and the US, Robert embarked upon a career change by moving into the charity sector in 2009. In a newly created role of Chief Operating Officer at The Anne Frank Trust UK, Robert’s responsibilities are to build on the Trust’s 20 years of growth and steer the organisation to its next set of ambitious goals. Robert’s motivation to join as a trustee stems from his belief that there is still too little being done for those who have been diagnosed with this forgotten cancer.
| || |
Dr. Steven Powell
Steven is a Trustee of The Brain Tumour Charity where he is both Chair of the Research Committee and the HeadSmart Board. Steven graduated in microbiology from the University of Wales and was awarded a PhD from the University of Aberdeen. He has over 25 years operational and investment experience in pharmaceutical and healthcare R&D and has held four CEO roles, two in public companies. In 2003, he joined Gilde Healthcare, a pan-European life sciences investment fund and remains an adviser to the fund. He is also an adviser to The CRT Pioneer Fund managed by Sixth Element Capital, which was established to bridge the investment gap between cancer drug discovery and early stage drug development. Operationally, Steven has helped finance and has overseen clinical trials in a number of cancer indications including leukaemia, pancreatic cancer, liver cancer, mesothelioma and brain tumours. In 2010, Steven was treated for leukaemia and, since entering remission, he has split his time between biotechnology corporate roles and supporting medical research charities; notably The Brain Tumour Charity.
| || |